Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pancreatitis, Chronic | 19 | 2024 | 282 | 8.840 |
Why?
|
Pancreatitis | 25 | 2024 | 1086 | 8.510 |
Why?
|
Pancreatic Function Tests | 5 | 2017 | 69 | 2.170 |
Why?
|
Exocrine Pancreatic Insufficiency | 3 | 2024 | 82 | 1.640 |
Why?
|
Acute Disease | 22 | 2024 | 7237 | 1.610 |
Why?
|
Secretin | 3 | 2017 | 57 | 1.560 |
Why?
|
Pancreatitis, Alcoholic | 2 | 2022 | 28 | 1.520 |
Why?
|
Endoscopy, Gastrointestinal | 19 | 2024 | 889 | 1.500 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 11 | 2024 | 520 | 1.230 |
Why?
|
Colonoscopy | 7 | 2022 | 1408 | 1.210 |
Why?
|
Alcoholism | 4 | 2022 | 1979 | 1.190 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2022 | 627 | 1.120 |
Why?
|
Endosonography | 6 | 2024 | 626 | 1.100 |
Why?
|
Lipase | 2 | 2021 | 320 | 1.090 |
Why?
|
Gallstones | 3 | 2022 | 285 | 0.970 |
Why?
|
Pancreas | 5 | 2023 | 1699 | 0.960 |
Why?
|
Gastroenterology | 6 | 2016 | 593 | 0.820 |
Why?
|
Pancreatic Neoplasms | 5 | 2024 | 5454 | 0.810 |
Why?
|
Adenoma | 5 | 2022 | 2155 | 0.770 |
Why?
|
Choledocholithiasis | 1 | 2022 | 50 | 0.760 |
Why?
|
Colonic Polyps | 5 | 2022 | 557 | 0.740 |
Why?
|
Patient Discharge | 2 | 2024 | 3465 | 0.690 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2023 | 364 | 0.680 |
Why?
|
Cholestasis | 6 | 2024 | 385 | 0.640 |
Why?
|
Bone Diseases, Metabolic | 1 | 2023 | 407 | 0.640 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2021 | 427 | 0.620 |
Why?
|
Restless Legs Syndrome | 1 | 2022 | 236 | 0.620 |
Why?
|
Pancreatic Juice | 1 | 2017 | 60 | 0.560 |
Why?
|
Critical Pathways | 2 | 2018 | 475 | 0.560 |
Why?
|
Bicarbonates | 1 | 2017 | 293 | 0.530 |
Why?
|
Opioid-Related Disorders | 2 | 2022 | 2177 | 0.520 |
Why?
|
Quality Indicators, Health Care | 3 | 2023 | 1804 | 0.510 |
Why?
|
Analgesics, Opioid | 7 | 2022 | 3836 | 0.500 |
Why?
|
Colorectal Neoplasms | 5 | 2022 | 6961 | 0.500 |
Why?
|
Publications | 1 | 2017 | 195 | 0.460 |
Why?
|
Watchful Waiting | 1 | 2018 | 492 | 0.450 |
Why?
|
Fellowships and Scholarships | 3 | 2021 | 1134 | 0.450 |
Why?
|
Hypertension, Portal | 4 | 1996 | 229 | 0.440 |
Why?
|
Length of Stay | 6 | 2023 | 6490 | 0.440 |
Why?
|
Peer Review, Research | 1 | 2017 | 342 | 0.430 |
Why?
|
Humans | 112 | 2024 | 766117 | 0.430 |
Why?
|
Osteoporosis | 1 | 2023 | 1582 | 0.430 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2022 | 1762 | 0.420 |
Why?
|
Clinical Competence | 5 | 2020 | 4859 | 0.410 |
Why?
|
Pilot Projects | 7 | 2023 | 8724 | 0.390 |
Why?
|
Curriculum | 8 | 2021 | 3784 | 0.390 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 4 | 2016 | 452 | 0.370 |
Why?
|
Hospitalization | 6 | 2024 | 10811 | 0.360 |
Why?
|
Fractures, Bone | 1 | 2023 | 2041 | 0.360 |
Why?
|
Retrospective Studies | 18 | 2024 | 81565 | 0.350 |
Why?
|
Emergency Service, Hospital | 4 | 2024 | 7871 | 0.310 |
Why?
|
Patient Readmission | 4 | 2024 | 3283 | 0.300 |
Why?
|
Cholecystectomy | 2 | 2020 | 409 | 0.290 |
Why?
|
Hospitals | 1 | 2020 | 3887 | 0.280 |
Why?
|
Hepatitis, Chronic | 1 | 2006 | 53 | 0.270 |
Why?
|
Cholangitis, Sclerosing | 2 | 2011 | 179 | 0.270 |
Why?
|
Drainage | 2 | 2024 | 1182 | 0.270 |
Why?
|
Risk Factors | 15 | 2024 | 74857 | 0.260 |
Why?
|
Critical Illness | 2 | 2017 | 2749 | 0.260 |
Why?
|
Periodicals as Topic | 1 | 2017 | 1463 | 0.250 |
Why?
|
Biliary Tract Diseases | 2 | 2024 | 160 | 0.250 |
Why?
|
Gastrostomy | 2 | 2024 | 325 | 0.240 |
Why?
|
Middle Aged | 36 | 2024 | 223083 | 0.240 |
Why?
|
Male | 49 | 2024 | 363935 | 0.230 |
Why?
|
Cyclooxygenase 2 | 1 | 2006 | 595 | 0.230 |
Why?
|
Adult | 39 | 2024 | 223139 | 0.220 |
Why?
|
Practice Guidelines as Topic | 7 | 2019 | 7424 | 0.220 |
Why?
|
Female | 43 | 2024 | 396233 | 0.220 |
Why?
|
Fundoplication | 1 | 2024 | 146 | 0.220 |
Why?
|
Diagnostic Imaging | 2 | 2015 | 3530 | 0.220 |
Why?
|
Review Literature as Topic | 2 | 2023 | 297 | 0.220 |
Why?
|
Liver Cirrhosis | 3 | 2006 | 1961 | 0.220 |
Why?
|
Pancreatic Hormones | 1 | 2022 | 12 | 0.210 |
Why?
|
Abdominal Pain | 2 | 2023 | 1069 | 0.210 |
Why?
|
Esophageal Neoplasms | 2 | 2023 | 1659 | 0.210 |
Why?
|
Stomach Neoplasms | 2 | 2023 | 1471 | 0.210 |
Why?
|
Chloride Channels | 2 | 2004 | 221 | 0.210 |
Why?
|
Sphincterotomy, Endoscopic | 1 | 2002 | 44 | 0.210 |
Why?
|
Fluid Therapy | 2 | 2024 | 587 | 0.210 |
Why?
|
Constriction, Pathologic | 5 | 2024 | 1102 | 0.210 |
Why?
|
Celiac Disease | 4 | 2011 | 820 | 0.200 |
Why?
|
Recurrence | 5 | 2022 | 8494 | 0.190 |
Why?
|
Stents | 6 | 2024 | 3191 | 0.190 |
Why?
|
Gastric Balloon | 1 | 2022 | 36 | 0.190 |
Why?
|
Analgesia, Patient-Controlled | 1 | 2022 | 117 | 0.190 |
Why?
|
Severity of Illness Index | 5 | 2024 | 15882 | 0.190 |
Why?
|
Acetylation | 1 | 2023 | 1054 | 0.180 |
Why?
|
Liver Transplantation | 2 | 2023 | 2417 | 0.180 |
Why?
|
Nerve Block | 2 | 2024 | 717 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8725 | 0.180 |
Why?
|
Helicobacter pylori | 3 | 2009 | 380 | 0.180 |
Why?
|
Chlorides | 1 | 2003 | 666 | 0.170 |
Why?
|
Time Factors | 10 | 2024 | 40108 | 0.170 |
Why?
|
Predictive Value of Tests | 5 | 2017 | 15403 | 0.170 |
Why?
|
Prescriptions | 1 | 2022 | 388 | 0.170 |
Why?
|
Inpatients | 2 | 2022 | 2566 | 0.170 |
Why?
|
Lung Diseases, Obstructive | 1 | 2001 | 309 | 0.170 |
Why?
|
Guidelines as Topic | 2 | 2017 | 1394 | 0.170 |
Why?
|
Esophageal Achalasia | 1 | 2021 | 99 | 0.170 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1729 | 0.160 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2021 | 119 | 0.160 |
Why?
|
Early Diagnosis | 2 | 2015 | 1186 | 0.160 |
Why?
|
Pain, Postoperative | 2 | 2022 | 1768 | 0.150 |
Why?
|
Preventive Medicine | 1 | 2000 | 246 | 0.150 |
Why?
|
Gallbladder Neoplasms | 1 | 2000 | 190 | 0.150 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12235 | 0.150 |
Why?
|
Enteral Nutrition | 1 | 2024 | 802 | 0.150 |
Why?
|
Megacolon, Toxic | 1 | 1998 | 8 | 0.150 |
Why?
|
Prospective Studies | 13 | 2020 | 54812 | 0.150 |
Why?
|
Collateral Circulation | 2 | 1996 | 289 | 0.150 |
Why?
|
Quality of Life | 4 | 2024 | 13468 | 0.150 |
Why?
|
Food Supply | 1 | 2024 | 544 | 0.150 |
Why?
|
Aged | 21 | 2024 | 171219 | 0.150 |
Why?
|
Duodenum | 3 | 2017 | 496 | 0.140 |
Why?
|
Encephalitozoonosis | 1 | 1997 | 2 | 0.140 |
Why?
|
Encephalitozoon | 1 | 1997 | 4 | 0.140 |
Why?
|
Endoscopes, Gastrointestinal | 1 | 2017 | 45 | 0.140 |
Why?
|
Gastroesophageal Reflux | 1 | 2024 | 834 | 0.140 |
Why?
|
Pain | 2 | 2022 | 5090 | 0.140 |
Why?
|
Bile Ducts | 2 | 2011 | 288 | 0.140 |
Why?
|
Feasibility Studies | 2 | 2018 | 5300 | 0.130 |
Why?
|
Conflict of Interest | 4 | 2014 | 556 | 0.130 |
Why?
|
Portal System | 1 | 1996 | 49 | 0.130 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2023 | 2271 | 0.130 |
Why?
|
Technetium Tc 99m Sulfur Colloid | 1 | 1996 | 63 | 0.130 |
Why?
|
Follow-Up Studies | 4 | 2024 | 39243 | 0.130 |
Why?
|
Endoscopy | 4 | 2021 | 1854 | 0.130 |
Why?
|
Aspartate Aminotransferases | 1 | 1998 | 416 | 0.130 |
Why?
|
Glycoproteins | 1 | 2023 | 2196 | 0.130 |
Why?
|
Hepatic Encephalopathy | 1 | 1997 | 143 | 0.130 |
Why?
|
Adenocarcinoma | 2 | 2023 | 6363 | 0.130 |
Why?
|
Body Fluids | 1 | 2017 | 321 | 0.130 |
Why?
|
Protein Processing, Post-Translational | 1 | 2023 | 1962 | 0.120 |
Why?
|
United States | 11 | 2023 | 72920 | 0.120 |
Why?
|
Diazinon | 1 | 1995 | 4 | 0.120 |
Why?
|
Capnography | 1 | 2016 | 90 | 0.120 |
Why?
|
Splenomegaly | 1 | 1996 | 191 | 0.120 |
Why?
|
Smoking | 2 | 2023 | 9082 | 0.120 |
Why?
|
Alanine Transaminase | 1 | 1998 | 608 | 0.120 |
Why?
|
Hepatitis | 1 | 1997 | 226 | 0.120 |
Why?
|
Societies, Medical | 5 | 2024 | 3955 | 0.120 |
Why?
|
Celiac Plexus | 2 | 2024 | 34 | 0.120 |
Why?
|
Massachusetts | 3 | 2024 | 8882 | 0.120 |
Why?
|
Pancreatic Diseases | 1 | 2017 | 353 | 0.120 |
Why?
|
Helicobacter Infections | 2 | 2009 | 390 | 0.120 |
Why?
|
Midazolam | 1 | 2016 | 267 | 0.110 |
Why?
|
Colonic Diseases | 1 | 2016 | 205 | 0.110 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2006 | 2327 | 0.110 |
Why?
|
Counseling | 1 | 2022 | 1553 | 0.110 |
Why?
|
Paralysis | 1 | 1995 | 248 | 0.110 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1997 | 663 | 0.110 |
Why?
|
Evidence-Based Medicine | 3 | 2014 | 3690 | 0.110 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12061 | 0.110 |
Why?
|
Cystic Fibrosis | 3 | 2016 | 1284 | 0.110 |
Why?
|
Cholinesterase Inhibitors | 1 | 1995 | 242 | 0.100 |
Why?
|
Sensitivity and Specificity | 4 | 2017 | 14645 | 0.100 |
Why?
|
Insecticides | 1 | 1995 | 203 | 0.100 |
Why?
|
Bronchial Diseases | 1 | 2014 | 151 | 0.100 |
Why?
|
Nose | 1 | 2016 | 519 | 0.100 |
Why?
|
Gastrointestinal Agents | 1 | 2017 | 511 | 0.100 |
Why?
|
Fentanyl | 1 | 2016 | 451 | 0.100 |
Why?
|
Gastrointestinal Diseases | 1 | 2001 | 1204 | 0.100 |
Why?
|
Workflow | 1 | 2017 | 859 | 0.100 |
Why?
|
Pain Measurement | 2 | 2020 | 3576 | 0.100 |
Why?
|
Gastric Mucosa | 2 | 2021 | 602 | 0.100 |
Why?
|
Pesticides | 1 | 1995 | 297 | 0.100 |
Why?
|
Sickness Impact Profile | 1 | 2013 | 297 | 0.100 |
Why?
|
Congresses as Topic | 1 | 2017 | 811 | 0.100 |
Why?
|
Pancreaticoduodenectomy | 1 | 2015 | 515 | 0.090 |
Why?
|
Pulmonary Medicine | 1 | 2014 | 223 | 0.090 |
Why?
|
Pneumothorax | 1 | 1995 | 393 | 0.090 |
Why?
|
Conscious Sedation | 1 | 2016 | 534 | 0.090 |
Why?
|
Obesity, Morbid | 1 | 2022 | 1293 | 0.090 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2108 | 0.090 |
Why?
|
Liver Neoplasms | 1 | 2006 | 4352 | 0.090 |
Why?
|
Pancreatectomy | 1 | 2015 | 825 | 0.090 |
Why?
|
Blood Coagulation | 1 | 1996 | 1169 | 0.090 |
Why?
|
Air | 1 | 2010 | 182 | 0.090 |
Why?
|
Mesalamine | 1 | 2011 | 133 | 0.090 |
Why?
|
Nephrology | 1 | 2014 | 270 | 0.080 |
Why?
|
Bone Density | 1 | 2023 | 3491 | 0.080 |
Why?
|
Antibiotic Prophylaxis | 1 | 2015 | 641 | 0.080 |
Why?
|
Benchmarking | 1 | 2016 | 1055 | 0.080 |
Why?
|
Case-Control Studies | 4 | 2021 | 22228 | 0.080 |
Why?
|
Hepatitis C, Chronic | 1 | 1998 | 1032 | 0.080 |
Why?
|
Rectal Diseases | 1 | 2010 | 141 | 0.080 |
Why?
|
Colon | 3 | 2010 | 1797 | 0.080 |
Why?
|
Prognosis | 4 | 2023 | 29912 | 0.080 |
Why?
|
Incidence | 4 | 2021 | 21513 | 0.080 |
Why?
|
Spleen | 1 | 1995 | 2294 | 0.080 |
Why?
|
Endoscopy, Digestive System | 2 | 2023 | 358 | 0.080 |
Why?
|
Academic Medical Centers | 2 | 2016 | 2782 | 0.080 |
Why?
|
Critical Care | 1 | 2001 | 2714 | 0.070 |
Why?
|
Insulin | 1 | 2022 | 6604 | 0.070 |
Why?
|
Patient Care | 1 | 2013 | 630 | 0.070 |
Why?
|
Internal Medicine | 1 | 2015 | 1064 | 0.070 |
Why?
|
Resuscitation | 2 | 2024 | 681 | 0.070 |
Why?
|
Intestines | 1 | 2016 | 1904 | 0.070 |
Why?
|
Irritable Bowel Syndrome | 1 | 2013 | 454 | 0.070 |
Why?
|
Urease | 1 | 2007 | 43 | 0.070 |
Why?
|
Cholangiocarcinoma | 2 | 2023 | 577 | 0.070 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2008 | 279 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2022 | 3407 | 0.070 |
Why?
|
Docosahexaenoic Acids | 2 | 2011 | 916 | 0.070 |
Why?
|
Inflammation | 2 | 2023 | 10860 | 0.070 |
Why?
|
Reproducibility of Results | 5 | 2017 | 20137 | 0.070 |
Why?
|
Colony Count, Microbial | 1 | 2007 | 326 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12529 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 1996 | 2702 | 0.070 |
Why?
|
Phototherapy | 1 | 2009 | 369 | 0.060 |
Why?
|
Bone Marrow | 1 | 1996 | 2916 | 0.060 |
Why?
|
Sleep | 1 | 2022 | 4816 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2024 | 5367 | 0.060 |
Why?
|
Breath Tests | 1 | 2007 | 297 | 0.060 |
Why?
|
Patient Care Team | 1 | 2017 | 2517 | 0.060 |
Why?
|
Age Factors | 2 | 2021 | 18386 | 0.060 |
Why?
|
Internship and Residency | 3 | 2021 | 5946 | 0.060 |
Why?
|
Treatment Outcome | 10 | 2024 | 65219 | 0.060 |
Why?
|
Liver | 3 | 2011 | 7559 | 0.060 |
Why?
|
Choledochostomy | 1 | 2024 | 16 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2013 | 12976 | 0.060 |
Why?
|
Ultrasonography | 5 | 2020 | 5988 | 0.060 |
Why?
|
Hemostatic Techniques | 1 | 2005 | 116 | 0.060 |
Why?
|
Calculi | 1 | 2024 | 48 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2013 | 2431 | 0.060 |
Why?
|
Pancreatic Pseudocyst | 1 | 2024 | 112 | 0.060 |
Why?
|
Aged, 80 and over | 7 | 2021 | 59515 | 0.060 |
Why?
|
Administration, Rectal | 1 | 2023 | 69 | 0.060 |
Why?
|
Quality Improvement | 1 | 2019 | 3849 | 0.060 |
Why?
|
Hernia, Hiatal | 1 | 2024 | 90 | 0.050 |
Why?
|
Esophageal and Gastric Varices | 2 | 1996 | 215 | 0.050 |
Why?
|
Cholecystitis, Acute | 1 | 2024 | 81 | 0.050 |
Why?
|
Aspirin | 1 | 2015 | 3135 | 0.050 |
Why?
|
Lithotripsy | 1 | 2024 | 137 | 0.050 |
Why?
|
Nasal Mucosa | 2 | 2004 | 416 | 0.050 |
Why?
|
Foreign-Body Migration | 1 | 2005 | 219 | 0.050 |
Why?
|
Sweat | 1 | 2003 | 57 | 0.050 |
Why?
|
Cohort Studies | 3 | 2021 | 41684 | 0.050 |
Why?
|
Liver Cirrhosis, Biliary | 1 | 2003 | 108 | 0.050 |
Why?
|
Common Bile Duct | 1 | 2002 | 106 | 0.050 |
Why?
|
Esophagogastric Junction | 1 | 2024 | 350 | 0.050 |
Why?
|
Pancreatic Ducts | 1 | 2024 | 331 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5889 | 0.050 |
Why?
|
Biliary Tract Neoplasms | 1 | 2024 | 186 | 0.050 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2002 | 121 | 0.050 |
Why?
|
Coronary Angiography | 1 | 2014 | 4498 | 0.050 |
Why?
|
Cholecystitis | 1 | 2002 | 181 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3238 | 0.050 |
Why?
|
Needles | 1 | 2024 | 460 | 0.050 |
Why?
|
Barrett Esophagus | 1 | 2024 | 494 | 0.040 |
Why?
|
Mutation | 3 | 2004 | 30209 | 0.040 |
Why?
|
Crohn Disease | 1 | 2013 | 2281 | 0.040 |
Why?
|
Image Enhancement | 1 | 2010 | 2857 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14747 | 0.040 |
Why?
|
Gastrectomy | 1 | 2024 | 693 | 0.040 |
Why?
|
Tacrolimus | 1 | 2023 | 754 | 0.040 |
Why?
|
Proton Pump Inhibitors | 1 | 2024 | 551 | 0.040 |
Why?
|
Budesonide | 2 | 2011 | 162 | 0.040 |
Why?
|
Dissection | 1 | 2021 | 298 | 0.040 |
Why?
|
Up-Regulation | 1 | 2008 | 4133 | 0.040 |
Why?
|
Fluoroscopy | 1 | 2023 | 945 | 0.040 |
Why?
|
Posture | 1 | 2023 | 955 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2011 | 3427 | 0.040 |
Why?
|
Deglutition Disorders | 1 | 2024 | 640 | 0.040 |
Why?
|
Chronic Disease | 1 | 2013 | 9354 | 0.040 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2005 | 1127 | 0.040 |
Why?
|
Clinical Enzyme Tests | 1 | 1998 | 114 | 0.040 |
Why?
|
Disclosure | 2 | 2014 | 756 | 0.040 |
Why?
|
Biopsy | 2 | 2001 | 6768 | 0.040 |
Why?
|
Bile Duct Neoplasms | 1 | 2023 | 624 | 0.040 |
Why?
|
Contrast Media | 1 | 2010 | 5330 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2023 | 870 | 0.040 |
Why?
|
Physicians | 1 | 2015 | 4591 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2249 | 0.030 |
Why?
|
Depressive Disorder | 1 | 2009 | 3712 | 0.030 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 1996 | 64 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2008 | 3684 | 0.030 |
Why?
|
Education, Medical, Graduate | 2 | 2021 | 2419 | 0.030 |
Why?
|
Ultrasonography, Interventional | 1 | 2024 | 1520 | 0.030 |
Why?
|
Gastric Bypass | 1 | 2024 | 820 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2019 | 738 | 0.030 |
Why?
|
Action Potentials | 1 | 2003 | 1834 | 0.030 |
Why?
|
Colitis | 1 | 2004 | 1240 | 0.030 |
Why?
|
Pralidoxime Compounds | 1 | 1995 | 5 | 0.030 |
Why?
|
Cholinesterase Reactivators | 1 | 1995 | 6 | 0.030 |
Why?
|
Fasciculation | 1 | 1995 | 9 | 0.030 |
Why?
|
Alkaline Phosphatase | 2 | 2011 | 855 | 0.030 |
Why?
|
Delphi Technique | 1 | 2019 | 893 | 0.030 |
Why?
|
Employment | 1 | 2021 | 1108 | 0.030 |
Why?
|
Chest Tubes | 1 | 1995 | 153 | 0.030 |
Why?
|
Atropine | 1 | 1995 | 243 | 0.030 |
Why?
|
Vertebral Artery | 1 | 1995 | 185 | 0.030 |
Why?
|
Myxoma | 1 | 1995 | 114 | 0.030 |
Why?
|
Muscarinic Antagonists | 1 | 1995 | 135 | 0.030 |
Why?
|
Portal Vein | 1 | 1996 | 437 | 0.030 |
Why?
|
Quadriplegia | 1 | 1995 | 227 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2001 | 1405 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1996 | 1607 | 0.030 |
Why?
|
Ciliary Motility Disorders | 1 | 1993 | 51 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11035 | 0.030 |
Why?
|
Life Style | 1 | 2024 | 3928 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2024 | 2768 | 0.030 |
Why?
|
Liver Diseases | 1 | 2001 | 1304 | 0.020 |
Why?
|
Arteriovenous Malformations | 1 | 1995 | 397 | 0.020 |
Why?
|
Family Practice | 1 | 2015 | 508 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 1996 | 1985 | 0.020 |
Why?
|
Bronchiectasis | 1 | 1993 | 141 | 0.020 |
Why?
|
Biopsy, Needle | 2 | 2011 | 1613 | 0.020 |
Why?
|
Hematocrit | 1 | 2013 | 622 | 0.020 |
Why?
|
Heart Neoplasms | 1 | 1995 | 374 | 0.020 |
Why?
|
Risk Assessment | 3 | 2019 | 24276 | 0.020 |
Why?
|
Prevalence | 2 | 2009 | 15827 | 0.020 |
Why?
|
Geriatrics | 1 | 2015 | 394 | 0.020 |
Why?
|
Administration, Oral | 2 | 2011 | 4016 | 0.020 |
Why?
|
Liver Function Tests | 1 | 2011 | 527 | 0.020 |
Why?
|
Genetic Testing | 1 | 2003 | 3594 | 0.020 |
Why?
|
Sex Distribution | 1 | 1995 | 2270 | 0.020 |
Why?
|
Pulmonary Emphysema | 1 | 1995 | 683 | 0.020 |
Why?
|
Disease Progression | 1 | 2006 | 13616 | 0.020 |
Why?
|
Monitoring, Intraoperative | 1 | 2016 | 946 | 0.020 |
Why?
|
Fibrosis | 1 | 1996 | 2073 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1998 | 6208 | 0.020 |
Why?
|
Age Distribution | 1 | 1995 | 2865 | 0.020 |
Why?
|
Anticoagulants | 1 | 2024 | 4857 | 0.020 |
Why?
|
Dehydration | 1 | 2010 | 215 | 0.020 |
Why?
|
Genotype | 1 | 2003 | 13028 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2010 | 1376 | 0.020 |
Why?
|
Pneumonectomy | 1 | 1995 | 1147 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2662 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2015 | 2426 | 0.020 |
Why?
|
Genetic Variation | 1 | 2003 | 6612 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 1998 | 2689 | 0.020 |
Why?
|
Hypnotics and Sedatives | 1 | 2016 | 1193 | 0.020 |
Why?
|
Reference Values | 1 | 1995 | 4909 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2024 | 10380 | 0.020 |
Why?
|
Heterozygote | 2 | 2004 | 2796 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4853 | 0.020 |
Why?
|
Spinal Cord | 1 | 1995 | 1811 | 0.020 |
Why?
|
Duodenoscopy | 1 | 2007 | 45 | 0.020 |
Why?
|
Child, Preschool | 3 | 2016 | 42511 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2011 | 1865 | 0.020 |
Why?
|
Education, Medical, Undergraduate | 1 | 2015 | 1087 | 0.020 |
Why?
|
Respiratory Tract Infections | 1 | 1993 | 1008 | 0.020 |
Why?
|
Patients | 1 | 2012 | 908 | 0.020 |
Why?
|
Parenteral Nutrition | 1 | 2010 | 661 | 0.020 |
Why?
|
Gastroscopy | 1 | 2007 | 212 | 0.020 |
Why?
|
Adolescent | 4 | 2016 | 88819 | 0.020 |
Why?
|
Phenotype | 1 | 2003 | 16716 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2023 | 22341 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2015 | 2235 | 0.010 |
Why?
|
Steroids | 1 | 2010 | 934 | 0.010 |
Why?
|
Intestine, Small | 1 | 2011 | 1216 | 0.010 |
Why?
|
Isoproterenol | 1 | 2004 | 398 | 0.010 |
Why?
|
Europe | 1 | 2011 | 3430 | 0.010 |
Why?
|
Gastrointestinal Tract | 1 | 2010 | 834 | 0.010 |
Why?
|
Infant | 2 | 2016 | 36427 | 0.010 |
Why?
|
Malnutrition | 1 | 2010 | 629 | 0.010 |
Why?
|
Ion Transport | 1 | 2004 | 322 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2016 | 3477 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 1995 | 8525 | 0.010 |
Why?
|
Consensus | 1 | 2013 | 3202 | 0.010 |
Why?
|
Dextran Sulfate | 1 | 2004 | 255 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9657 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5531 | 0.010 |
Why?
|
Equipment Failure | 1 | 2005 | 580 | 0.010 |
Why?
|
Headache | 1 | 2011 | 1259 | 0.010 |
Why?
|
Antigens, Bacterial | 1 | 2008 | 1147 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 2007 | 1138 | 0.010 |
Why?
|
Stomach | 1 | 2007 | 702 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9335 | 0.010 |
Why?
|
Young Adult | 3 | 2016 | 59868 | 0.010 |
Why?
|
Child | 3 | 2016 | 80573 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2011 | 2156 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2004 | 1085 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3801 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 2007 | 1473 | 0.010 |
Why?
|
Animals | 3 | 2023 | 168800 | 0.010 |
Why?
|
Gene Deletion | 1 | 2008 | 2667 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7474 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2010 | 1805 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 4054 | 0.010 |
Why?
|
Mice | 2 | 2023 | 81839 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 13085 | 0.010 |
Why?
|
Homozygote | 1 | 2004 | 1774 | 0.010 |
Why?
|
Sodium | 1 | 2004 | 1591 | 0.010 |
Why?
|
Biomedical Research | 1 | 2014 | 3458 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12827 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2003 | 2111 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2008 | 3830 | 0.010 |
Why?
|
Infant, Newborn | 1 | 1995 | 26381 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2009 | 3445 | 0.010 |
Why?
|
Cell Line | 1 | 2008 | 15546 | 0.010 |
Why?
|
Angiography, Digital Subtraction | 1 | 1995 | 331 | 0.010 |
Why?
|
Rupture | 1 | 1995 | 444 | 0.010 |
Why?
|
Oligospermia | 1 | 1993 | 61 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 9527 | 0.010 |
Why?
|
Diet | 1 | 2010 | 8087 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 1995 | 20700 | 0.010 |
Why?
|
Veins | 1 | 1995 | 769 | 0.010 |
Why?
|
Neck | 1 | 1995 | 735 | 0.010 |
Why?
|
Laparoscopy | 1 | 2001 | 2040 | 0.000 |
Why?
|
Heart Atria | 1 | 1995 | 1363 | 0.000 |
Why?
|
Mice, Knockout | 1 | 2004 | 14456 | 0.000 |
Why?
|
Palliative Care | 1 | 2003 | 3639 | 0.000 |
Why?
|
Diagnostic Errors | 1 | 1995 | 1276 | 0.000 |
Why?
|
Heart Valve Diseases | 1 | 1995 | 1029 | 0.000 |
Why?
|
Syndrome | 1 | 1993 | 3270 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2009 | 15808 | 0.000 |
Why?
|
Hypertension, Pulmonary | 1 | 1995 | 1604 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 1995 | 36548 | 0.000 |
Why?
|